STORA ENSO OYJ INVESTOR NEWS 12 December
2023 at 14:45 EET
HELSINKI, Dec. 12,
2023 /PRNewswire/ -- Stora Enso will record non-cash
impairments of approximately EUR 514
million in its IFRS operating result in the fourth quarter
of 2023. The impairments will be reported as an item affecting
comparability (IAC). Including the estimated positive tax effect of
EUR 65 million, the net result impact
will be approximately EUR 449 million
negative.
The impairment charges are allocated between the segments
as follows:
EUR
million
|
Goodwill
|
Fixed
assets
|
Total
impairment
|
Packaging
Materials
|
26
|
355
|
381
|
Biomaterials
|
45
|
58
|
103
|
Wood
Products
|
—
|
15
|
15
|
Other
|
—
|
15
|
15
|
Total
|
71
|
443
|
514
|
The fixed asset impairments in the Packaging Materials division
mainly relate to the Business Unit Containerboard and in the
Biomaterials division to the Nordic production units. The
impairments are mainly a consequence of Stora Enso's predictions of
a weaker outlook compared to previous estimates.
As a result of the impairment booking, the annual depreciation
will decrease by approximately EUR 40
million going forward. The impairments do not impact Stora
Enso's full-year 2023 guidance.
Investor enquiries:
Anna-Lena Åström
SVP Investor Relations
tel. +46 70 210 7691
Part of the global bioeconomy, Stora Enso is a leading
provider of renewable products in packaging, biomaterials and
wooden construction, and one of the largest private forest owners
in the world. We believe that everything that is made from
fossil-based materials today can be made from a tree tomorrow.
Stora Enso has approximately 21,000 employees and our sales in 2022
were EUR 11.7 billion. Stora Enso
shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq
Stockholm AB (STE A, STE R). In addition, the shares are traded in
the USA as ADRs and ordinary
shares (SEOAY, SEOFF, SEOJF). storaenso.com/investors
STORA ENSO OYJ
Investor enquiries:
Anna-Lena Åström
SVP Investor Relations
tel. +46 70 210 7691
View original
content:https://www.prnewswire.co.uk/news-releases/stora-ensos-fourth-quarter-2023-impairment-test-results-302012673.html